Hypothesis

Chronic nociceptor activity releases CGRP that modulates Wnt/β‑catenin signaling in intestinal stem cells (ISCs), linking pain perception to epithelial renewal. When CGRP tone falls—due to analgesic overuse or age‑related dysregulation—Wnt/β‑catenin activity becomes either overly suppressed or erratically hyperactive, impairing niche homeostasis and accelerating intestinal aging. Conversely, developmental loss of TRPV1 prevents dependence on this cue, allowing compensatory pathways to maintain Wnt balance, which explains the longevity of TRPV1 KO mice. Acute pharmacological blockade in adults removes a tonic signal that ISCs have evolved to interpret as a "damage‑alert" cue, leading to defective stem‑cell proliferation and barrier repair, thereby increasing mortality risk despite short‑term metabolic improvements.

Mechanistic rationale

1. TRPV1‑positive sensory nerves innervate the gut lamina propria and release CGRP upon activation by low‑grade noxious stimuli (e.g., microbiota‑derived metabolites, mechanical stretch).
2. CGRP binds its receptor (RAMP1/CLR) on subepithelial stromal cells and Paneth cells, triggering cAMP/PKA pathways that phosphorylate β‑catenin at Ser552, enhancing its nuclear translocation and transcriptional co‑activation with TCF/LEF.
3. This phosphorylation fine‑tunes Wnt ligand secretion from Paneth cells, creating a spatially restricted Wnt gradient optimal for ISC proliferation without triggering oncogenic β‑catenin accumulation.
4. In aged wild‑type mice, chronic low‑grade inflammation desensitizes TRPV1, reducing CGRP release; the resulting drop in β‑catenin phosphorylation shifts Wnt signaling toward a low‑activity state, diminishing ISC renewal and promoting barrier leak.
5. Pharmacological CGRP‑R blockade in older mice can transiently restore β‑catenin phosphorylation by removing inhibitory feedback (as shown in metabolic studies), but sustained blockade eliminates the tonic CGRP cue, causing Wnt signaling to become unresponsive to physiological fluctuations, thus impairing adaptive niche remodeling.
6. Developmental TRPV1 loss triggers upregulation of alternative neuropeptides (e.g., VIP) that can substitute for CGRP in stimulating β‑catenin phosphorylation, preserving Wnt homeostasis and accounting for the observed lifespan extension.

Testable predictions

• Prediction 1: Intestinal tissue from TRPV1‑KO mice will show baseline β‑catenin‑Ser552 phosphorylation levels comparable to young wild‑type mice, whereas aged wild‑type mice will exhibit a significant reduction; acute CGRP‑R antagonist treatment in aged mice will transiently increase phosphorylation but chronic treatment will abolish the stimulus‑dependent phosphorylation response. Test: Western blot or phospho‑specific immunofluorescence on isolated crypts from young, aged, TRPV1‑KO, and aged mice treated with CGRP‑R antagonist (short‑term 2 h vs. long‑term 4 weeks).

• Prediction 2: Optogenetic activation of TRPV1‑positive sensory neurons will increase Wnt ligand (e.g., Wnt3a) expression in neighboring Paneth cells and elevate nuclear β‑catenin in ISCs, an effect blocked by CGRP‑R antagonism. Test: Use Cre‑dependent Channelrhodopsin in TRPV1‑Cre mice; stimulate nerves ex vivo and measure Wnt3a mRNA (qPCR) and β‑catenin localization (confocal).

• Prediction 3: Mice subjected to chronic morphine therapy will develop intestinal barrier dysfunction (increased FITC‑dextran permeability) and reduced ISC Ki‑67 index, which can be rescued by concurrent low‑dose CGRP agonist administration that does not affect analgesia. Test: Long‑term morphine treatment with/without CGRP agonist; assess permeability, crypt proliferation, and survival.

Falsifiability

If any of the above experiments show that CGRP manipulation does not alter β‑catenin phosphorylation, Wnt ligand output, or ISC dynamics as predicted, the hypothesis that nociceptor‑derived CGRP directly tunes Wnt/β‑catenin signaling in the intestinal stem‑cell niche would be refuted. Conversely, consistent support would link analgesic use to a measurable disruption of a neuro‑Wnt axis that governs tissue renewal and organismal longevity.